Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.553
+0.024 (4.54%)
At close: Apr 28, 2026, 4:00 PM EDT
0.553
0.00 (0.00%)
After-hours: Apr 28, 2026, 8:00 PM EDT
Xtant Medical Holdings Revenue
In the year 2025, Xtant Medical Holdings had annual revenue of $133.93M with 14.21% growth. Xtant Medical Holdings had revenue of $32.36M in the quarter ending December 31, 2025, with 2.68% growth.
Revenue (ttm)
$133.93M
Revenue Growth
+14.21%
P/S Ratio
0.58
Revenue / Employee
$577,272
Employees
232
Market Cap
77.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 133.93M | 16.66M | 14.21% |
| Dec 31, 2024 | 117.27M | 25.96M | 28.44% |
| Dec 31, 2023 | 91.30M | 33.33M | 57.50% |
| Dec 31, 2022 | 57.97M | 2.71M | 4.90% |
| Dec 31, 2021 | 55.26M | 1.93M | 3.61% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Outset Medical | 119.48M |
| LENSAR | 58.44M |
| MaxCyte | 33.03M |
| Sensus Healthcare | 27.48M |
| Baird Medical Investment Holdings | 22.54M |
| Spectral AI | 19.65M |
| QT Imaging Holdings | 18.93M |
| InspireMD | 8.98M |
XTNT News
- 15 days ago - Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product - PRNewsWire
- 19 days ago - Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial - PRNewsWire
- 4 weeks ago - Xtant Medical Holdings Earnings Call Transcript: Q4 2025 - Transcripts
- 4 weeks ago - Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results - PRNewsWire
- 4 weeks ago - Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026 - PRNewsWire
- 2 months ago - Xtant Medical Holdings Transcript: 2026 CG Musculoskeletal Conference - Transcripts
- 2 months ago - Xtant Medical Finalizes Companion Spine Transactions - PRNewsWire
- 2 months ago - Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference - PRNewsWire